Horm Metab Res 2013; 45(08): 556-560
DOI: 10.1055/s-0033-1341485
Original Basic
© Georg Thieme Verlag KG Stuttgart · New York

Decreased Permeability Surface Area for Glucose in Obese Women with Postprandial Hyperglycemia: No Effect of Phosphodiesterase-5 (PDE-5) Inhibition

M. Sandqvist
1   The Lundberg Laboratory for Diabetes Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
,
L. Strindberg
1   The Lundberg Laboratory for Diabetes Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
2   Department of Molecular and Clinical Medicine, The Wallenberg Laboratory, Sahlgrenska Center for Cardiovascular and Metabolic Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
,
P. Lönnroth
2   Department of Molecular and Clinical Medicine, The Wallenberg Laboratory, Sahlgrenska Center for Cardiovascular and Metabolic Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
,
P.-A. Jansson
1   The Lundberg Laboratory for Diabetes Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
2   Department of Molecular and Clinical Medicine, The Wallenberg Laboratory, Sahlgrenska Center for Cardiovascular and Metabolic Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
› Author Affiliations
Further Information

Publication History

received 24 October 2012

accepted 11 March 2013

Publication Date:
23 April 2013 (online)

Preview

Abstract

Insulin-mediated microvascular recruitment is recognized as a potential mechanism contributing to insulin resistance. In this study, we compared a marker of microvascular function, the permeability surface area for glucose (PSglu), and forearm glucose uptake after an OGTT in obese women with impaired glucose metabolism and healthy lean nondiabetic women, with the aim to characterize whether decreased permeability surface area for glucose or decreased glucose uptake may contribute to postprandial hyperglycemia in the obese group. In addition, we evaluated whether the phosphodiesterase-5 (PDE-5) inhibitor tadalafil, in a randomized double blind placebo controlled design, might attenuate postprandial glucose levels in obese women. For these purposes, intramuscular microdialysis, blood sampling from arterial and venous blood of the forearm, and measurements of forearm blood flow were performed. The results showed an impaired permeability surface area for glucose (IAUC PSglu 31±13 vs. 124±31; p<0.05) in obese when compared with lean participants, but no differences in forearm glucose uptake appeared between the groups. Furthermore, a single dose of tadalafil 10 mg showed no improvement of the permeability surface area for glucose, glucose uptake, or circulating glucose levels in obese participants. In conclusion, the postprandial PSglu response was impaired in obese women showing postprandial hyperglycemia, indicating a compromised microcirculation. However, we were unable to demonstrate any acute effect on either vascular function or glucose uptake of the phosphodiesterase-5 (PDE-5) inhibitor tadalafil.